|
ZFP112 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.29349997169248E-09 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.47889999638318E-08 |
| Normal-vs-Stage2 |
1.29829999995223E-06 |
| Normal-vs-Stage3 |
3.87819998337591E-09 |
| Normal-vs-Stage4 |
7.30859817110741E-11 |
| Stage1-vs-Stage2 |
6.683000E-01 |
| Stage1-vs-Stage3 |
2.143600E-01 |
| Stage1-vs-Stage4 |
1.088030E-02 |
| Stage2-vs-Stage3 |
2.148800E-01 |
| Stage2-vs-Stage4 |
1.130290E-02 |
| Stage3-vs-Stage4 |
1.443040E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.80599995963848E-09 |
| Normal-vs-AfricanAmerican |
3.642300E-04 |
| Normal-vs-Asian |
1.73179999995998E-06 |
| Caucasian-vs-AfricanAmerican |
5.156400E-01 |
| Caucasian-vs-Asian |
2.756800E-01 |
| AfricanAmerican-vs-Asian |
8.934400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.85980000289021E-08 |
| Normal-vs-Female |
5.75339997865854E-09 |
| Male-vs-Female |
8.811400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.9365000127396E-09 |
| Normal-vs-Age(41-60Yrs) |
2.96309999869848E-08 |
| Normal-vs-Age(61-80Yrs) |
4.01569999475271E-09 |
| Normal-vs-Age(81-100Yrs) |
3.981200E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.067000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.369200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.891800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.143600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.260400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.737600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.55430000000112E-05 |
| Classical-VS-Follicular |
2.630000E-01 |
| Classical-VS-Other |
6.183000E-01 |
| Classical-VS-Normal |
1.21959999987986E-07 |
| Tall-VS-Follicular |
1.173830E-02 |
| Tall-VS-Other |
4.911200E-01 |
| Tall-VS-Normal |
1.97649674404943E-11 |
| Follicular-VS-Other |
9.108600E-01 |
| Follicular-VS-Normal |
4.4313000047147E-08 |
| Other-VS-Normal |
1.437760E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.91489999809858E-08 |
| Normal-vs-N1 |
1.86049997630278E-09 |
| N0-vs-N1 |
8.707900E-02 |
|
|
